GoDubai
  
  
  
  
Citylife > Press Release
  Home Contact us Add to Favourites
Most Recent Postings
More Press Releses
Featured Sections

Event Finder
A daily roundup of exhibitions, promotions and other events in Dubai and the rest of the Emirates.
Submit an Event
Latest Dubai Press Releases >>

 
  Share
Fast facts:
- Cancer is a leading cause of death worldwide - when caught in its early stages, before metastasis (which is the growth of a secondary tumor separate to the primary site of cancer), it is known that cancer survival rates are higher
- NYUAD researchers have developed a new fluid analyzing platform that allows for  the isolation of circulating tumor cells (CTCs), which are formed during metastasis 
- The new technology, featured in the Nature journal Microsystems and Nanoengineering, enables the effective isolation of CTCs from prostate cancer patients' blood samples, and allows for high precision analysis of CTCs' mechanical  properties at the single cell level 
- The new platform could potentially constitute an important test for monitoring and studying metastasis, and can also be used to monitor other types of the disease such as breast and lung cancers
 
Abu Dhabi, UAE, March 23, 2020: Cancer is one of the leading causes of death worldwide, and has been found to have a significantly higher rate of survival when diagnosed at early stages, before metastasis. During metastasis, a secondary growth is initiated by circulating tumor cells (CTCs) that shed from the primary tumor into the bloodstream to spread the cancer. A team of engineering researchers from NYU Abu Dhabi, led by NYUAD Assistant Professor of Mechanical and Biomedical Engineering Mohammad A. Qasaimeh, has developed a microfluidic platform that is compatible with cutting-edge procedures of atomic force microscopy (AFM). 
 
The developed platform is used to capture CTCs from blood samples of prostate cancer patients, followed by AFM mechanical characterizations of CTCs, at the nanoscale, in search for new metastatic mechano-biomarkers.
 
While the general lifecycle of CTCs is somewhat recognized, the lifespan and interactions of CTCs while circulating in the bloodstream is still unknown.  CTCs are very rare and hard to isolate from the background of billions of healthy blood cells, and thus their biological and mechanical phenotypes are still to be explored. 
 
The developed new tool allows for isolation and characterization of CTCs and thus holds the potential to assist in the early detection of cancer. It also can be used as a tool to more effectively track and monitor cancer progression and metastasis. 
 
In the paper titled AFM-compatible Microfluidic Platform for Affinity-based Capture and Nanomechanical Characterization of Circulating Tumor Cells published in the Microsystems and Nanoengineering journal , the researchers presented the microfluidic technology they developed to separate CTCs from blood samples for further analysis. The CTCs were isolated from other blood cells by noting the differences in their affinity to different monoclonal antibodies. The developed tool is a combined microfluidic-AFM platform, where AFM analyses can be followed to investigate the elasticity and adhesive properties of the captured CTCs cancer cells.
 
CTCs represent a biomarker for the detection, diagnosis, and prognosis of cancer. As CTCs spread through the bloodstream, using their discovered characteristics, they can be removed through a liquid biopsy procedure. 
 
Isolated CTCs can be potentially used for drug testing and molecular profiling for precision cancer therapies. Far less invasive than a traditional tissue biopsy, liquid biopsy procedures have the potential to replace traditional tissue biopsies in the near future, and be performed in local clinics or pharmacies. 
 
“We expect that this platform could constitute a potentially very powerful tool for cancer diagnosis and prognosis, by identifying CTCs mechanical and biological phenotypes at the single cell level,” said Mohammad A. Qasaimeh. 
 
“With slight customizations, the platform can also be adapted to other types of cancers including breast and lung,” said the first author of the study and the Research Scientist of Engineering at NYUAD, Muhammedin Deliorman.
 
The authors hope that using the developed tool, nanomechanical properties of captured CTCs could help in the future to identify aggressive cancer CTCs phenotypes for developing more effective therapies.



Posted by : GoDubai Editorial Team
Viewed 3891 times
Posted on : Monday, March 23, 2020  
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of GoDubai.com.
Next Story : MBRU Improves Medical Care Services Through Organ Transplantation
Email this article Print this article

Share this article with your friends and followers
NewsVine

Comments

Back to Top  
Most Viewed Press Release posted in the last 7 days
Make Up for Ever Introduces for the First Time Its New Active Care-in-foundation...
Olay Eyes Hydra Gel
Maillon De Cartier Watch
LG Prioritizes Home Comfort With Latest Air Conditioners for GCC Market
6 Steps X 6 Products from Essence: The Shortcut that Perfects Skin - Now more th...
Kristina Fidelskaya A/W 2020 Collection “Dream”
Eid Gifts From The Body Shop
Ralph Lauren Expands Its Earth Polo Offering, Reinforces Commitment to Protectin...
Happy Eid with Parmigiani Fleurier Toric Fleur
Vatika Focuses on Making Quarantine a Quality Time With New Viral Campaign
Your at-Home Spa Guide With Skin Republic
Sony Middle East & Africa Launches New Compact 4K Handycam® Camcorder with Advan...
Dubai Sports Council Thanks Wise Leadership for Its Protection and Care of the C...
UAE Banks Among Top Performing in GCC, KPMG Report Finds
Dubai Customs: Strategic Plan to Curb Corona
Etihad Guest Rewards Members While Staying Home
Denim Culture
Etihad Holidays to Be Operated by Dnata Travel Group In the UK
Mohap Hails Family Doctors' Efforts in Countering Covid-19 Crisis
Pure Health Launches Covid-19 Field Laboratory at Sharjah Expo Centre
Celebrate Father's Day With Parmigiani Fleurier Tondagraph Slate
Lenovo's Tech Gift Guide
First Range Rover Made Under Social Distancing Measures Comes Off Jaguar Land R...
Made in Italy, ICSA® Issues a Notification of Counterfeit Products Found in the ...
Karl Lagereld Drives Digital Innovation With Launch of the “Maison Karl Lagerfe...
Emirates Post Launches ‘Epostcard' to Connect Friends and Families
Instagram Partners with TBWA Raad and Egyptian Food Bank to #Stopfoodwaste
Covid-19 Disruption Will Lead to 28 Million Surgeries Cancelled Worldwide
Etihad Airways Increases Number and Frequency of Special Flights Worldwide
IATA Outlines Layered Approach for Industry Re-Start
Union Coop Launched ‘Drive Thru' Shopping Service
Ralph Lauren: How to master the art of tie-dye. #RLatHome
Abu Dhabi University Creates Face Shield Prototype to Support the Local Healthca...
MHPS Captures Global Gas Turbine Market Share Leadership Again
Dubai Chamber and Al Tamimi & Co discuss Covid-19 and Force Majeure in the UAE
Emirates Sets Industry-leading Safety Standard for Customers Travelling as It Re...
Keeping Mobile Networks Running Top Priority During COVID-19 Pandemic
Commodity Weekly: Gold and Silver Pop as Economic Clouds Darken
Jaguar Land Rover Special Vehicle Operations Reports Fiscal 2019/20 Retail Sale...
OMEGA Adds Full Gold Models to The Speedmaster 38 mm Collection
ENEC Completes Significant Test for Unit 4 at Barakah
SRTI Park Discusses Reality, Future of Research and Development in Arab Region
Introducing the Marks & Spencer Summer Edit
Jameel Institute at Imperial College London Launches New Tool to Help Hospitals ...
Arabian Automobiles Welcomes the All-New 2020 Nissan Sunny
Give the Gift of Time and Convenience This Eid With Lg Electronics
Abu Dhabi Early Childhood Authority: How to Help Your Children Thrive With Remot...
What Narcolepsy Is and How to Cope With It
UAE Develops a Rapid Coronavirus Laser Testing Technology
Twitter Launches ‘Heroes of Good' Campaign to Celebrate the Spirit of Ramadan